Intensive dialysis and blood pressure control: A review

Hemodialysis International

Volumn 8, Issue 1, 2004, Pages 51-60

  Charra, Bernard ^a   Jean, Guillaume ^a   Chazot, Charles ^a   Hurot, Jean Marc ^a   Terrat, Jean Claude ^a   Vanel, Thierry ^a   Lorriaux, Christie ^a   Vovan, Cyril ^a  

^a Center de Rein Artificiel   (France)

Author keywords

Blood pressure; Diet; Dose; Hemodialysis; Sodium; Time

Indexed keywords

SODIUM; UREA;

BLOOD PRESSURE REGULATION; DEHYDRATION; DISEASE SEVERITY; EXTRACELLULAR SPACE; FLUID RETENTION; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHESIS; INTENSIVE CARE; KIDNEY FAILURE; LONG TERM CARE; MORBIDITY; MORTALITY; PREVALENCE; REVIEW; SODIUM RESTRICTION; STEADY STATE; TREATMENT OUTCOME; UREA BLOOD LEVEL;

EID: 22744437087     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2004.00075.x     Document Type: Review

References (63)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription on patient morbidity: Report from the National Cooperative Study. N Engl J Med. 1981; 305(20):1176-1181.
2. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Study (NCDS). Kidney Int. 1985; 28(3):526-534.
3. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WFJ. The urea (clearance × dialysis time) product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int. 1999; 56:729-737.
4. Hegström RM, Murray JS, Pendras JP, Burnell JM, Scribner BH. Hemodialysis in the treatment of chronic uremia. Trans Am Soc for Artif Intern Organs. 1961; 7:136-152.
5. Sellars L, Robson V, Wilkinson R. Sodium retention and hypertension with short dialysis. Br Med J. 1979; 1(6162):520-521.
6. Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis. 1992; 19(5): 453-459.
7. Wizemann V, Kramer W. Short-term dialysis - long-term complications: Ten years experience with short-duration renal replacement therapy. Blood Purif. 1987; 5(4):193-201.
8. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodiaysis patients. Am J Kidney Dis. 1999; 33(3):507-517.
9. Degoulet P, Legrain M, Reach I, Aimé F, Devriès C, Rojas P, Jacobs C. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron. 1982; 31(2):103-110.
10. Charra B. Does empirical long slow dialysis result in better survival? If so, how and why? ASAIO J. 1993; 39(4): 819-822.
11. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol. 1996; 16(1): 35-44.
12. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. [published erratum appears in Kidney Int. 1998; 54(4):1417]. Kidney Int. 1998; 54(2):561-569.
13. Charra B, Laurent G, Calemard E, Chazot C, Terrat JC, Vanel T, Ruffet M. Risk factors involved in atherosclerotic events observed in HD patients. In: Man NK, Botella J, Zucchelli P, ezds. Blood Purification in Perspective: New Insights and Future Trends II. Cleveland (OH): ICAOT Press, 1992; 83-88.
14. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis. 1993; 21(5 suppl 2):113-118.
15. Foley RN, Parfrey PS, Harnett JD. Hypertension, cardiomyopathy, cardiac morbidity and mortality in ESRD. J Am Soc Nephrol. 1995; 6(3):529.
16. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996; 49: 1428-1434.
17. Wizemann V, Mueller K, Kramer W, Schütterle G. Ten years experience with short dialysis: A decade of cardiovascular complications [abstract]. Nephrol Dial Transplant. 1986; 1:100.
18. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC, Calemard E, Vanel T, Ruffet M. Interdialysis blood pressure control by long hemodialysis sessions. Nephrol Dial Transplant. 1995; 10(6):831-837.
19. Charra B, Ouais E. Long dialysis, cardiovascular morbidity and mortality. In: Timio M, Wizemann V, Venanzi S, eds. Cardionephrology. Cosenza: Editoriale Bios, 1997; 241-244.
20. MacGregor DO, Buttimore AL, Gary Nicholls M, Lynn KL. Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis. Nephrol Dial Transplant. 1999; 14(11):2676-2679.
21. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41:1286-1291.
22. Ackrill P, Goldsmith DJA, Covic AA, Venning MC, Ralston AJ. Outcome of long hours self-care haemodialysis in a single unit from 1969 through 1994. Nephrology. 1997; 3(suppl 1):S536.
23. de Palma JR. A new automatic coil dialyzer system for 'daily' dialysis. Proc Eur Dial Transplant Assoc. 1969; 6:26-34.
24. Galland R, Traeger J, Delawari E, Arkouche W. Control of hypertention and regression of left ventricular hypertrophy by daily hemodialysis [abstract]. J Am Soc Nephrol. 1999; 10:279A.
25. Pierratos A. Daily hemodialysis: An update. Curr Opin Nephrol Hypertens. 2002; 11(2):165-171.
26. Özkahya M, Töz H, Ünsal A, Özerkan F, Asci G, Gürgün C, Akcicek F, Mees EJ. Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis. 1999; 34(2):218-221.
27. Sulkova S, Valek A. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int Suppl. 1988; 25:S198-S200.
28. Rupp JW, Stone RA, Gunning BE. Sodium versus sodium-fluid restriction in hemodialysis: Controls of weight gains and blood pressure. Am J Clin Nutr. 1978; 31:1952-1955.
29. Shaldon S. Dietary salt restriction and drug-free treatment of hypertension in ESRD patients: A largely abandoned therapy. Nephrol Dial Transplant. 2002; 17:1163-1165.
30. Schreiber MJ Jr. Clinical case-based approach to understanding intradialytic hypotension. Am J Kidney Dis. 2001; 38(4 suppl 4): S37-S47.
31. Daugirdas JT. Pathophysiology of dialysis hypotension: An update. Am J Kidney Dis. 2001; 38(4 suppl 4): S11-S17.
32. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant. 2002; 17(9):1661-1666.
33. Faller B, Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant. 1994; 9(3):280-286.
34. Scribner BH. Discussion. Trans Am Soc Artif Intern Organs 1962; VIII:298.
35. Zucchelli P, Zuccala A, Santoro A, Sturani A, Esposti ED, Ligabue A, Chiarini C. Management of hypertension in dialysis. Int J Artif Organs. 1980; 3(2):78-84.
36. Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis. 1996; 28(2):257-261.
37. Charra B, Bergström J, Scribner BH. Blood pressure control in dialysis patients: The importance of the lag phenomenon. Am J Kidney Dis. 1998; 32(5):720-724.
38. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, Hoeks AP, van Kreel B, Gladziwa U, van der Sande FM, Leunissen KM. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 2002; 22(4):477-487.
39. Katzarski KS, Wang T, Heimburger O, Stenwinkel P, Qureshi AR, Bergström J, Lindholm B. Relation between fluid state, blood pressure and night ultrafiltration in peritoneal dialysis [abstract]. J Am Soc Nephrol. 1998; 9:284A.
40. Günal Al, Duman S, Özkahya M, Toz H, Asci G, Akçiçek F, Basci A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001; 37:588-593.
41. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: Evidence from a longitudinal study. Nephrol Dial Transplant. 2003; 18(4):797-803.
42. Vertes V, Cangiano JL, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med. 1969; 280(18):978-981.
43. Charra B, Chazot C, Laurent G, Calemard E, Terrat JC, Vanel T, Jean G, Ruffet M. Clinical assessment of dry weight. Nephrol Dial Transplant. 1996; 11(suppl 2):16-19.
44. Henderson LW. Symptomatic hypotension during hemodialysis. Kidney Int. 1980; 17(5):571-576.
45. Tomson CRV. Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time [editorial]. Nephrol Dial Transplant. 2001; 16(8):1538-1542.
46. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patient. Kidney Int. 2001; 60(4):1555-1560.
47. Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant. 1999; 14(12):2835-2840.
48. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001; 38(2): 371-376.
49. Galland R, Traeger J, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis. 2001; 37(1 suppl 2):S95-S98.
50. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, Gerlag PG, Hoorntje SJ, Wolters J, van der Sande FM, Leunissen KM. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: A randomized study. Kidney Int. 2003; 63(4):1556-1563.
51. Charra B, Chazot C, Jean G, Laurent G. Long, slow dialysis. Miner Elecrolyte Metab. 1999; 25(4-6):391-396.
52. Charra B, Laurent G. Long hemodialysis: The key to survival? In: Brown EA, Parfrey PS, eds. Complications of Long-Term Dialysis. Oxford/New York/Tokyo: Oxford University Press, 1999; 228-256.
53. Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E, Terrat JC, Ruffet M, Laurent G. The Janus-faced aspect of 'dry weight'. Nephrol Dial Transplant. 1999; 14(1):121-124.
54. Vallance P, Leone A, Calvet A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992; 339(8793):572-575.
55. Zoccali C, Bode-Boger SM, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet. 2002; 358(9299):2113-2117.
56. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R, CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002; 13(2):490-496.
57. Traeger J, Galland R, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis: A four-year experience. Dial Transplant. 2001; 30(2):76-86.
58. Pierratos A. Daily hemodialysis: Is it a complex therapy with unproven benefits? Blood Purif. 2001; 19(2): 206-210.
59. Port FK, Orzol SM, Held PJ, Wolfe RA. Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis. 1998; 32(6 suppl 4): S34-S38.
60. Lynn KL, McGregor DO, Moesbergen T, Buttimore AL, Inkster JA, Wells JE. Hypertension as a determinant of survival for patients treated with home dialysis. Kidney Int. 2002; 62(6):2281-2287.
61. Tonelli M, Bohm C, Paneya S, Gill J, Levin A, Kiberd BA. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001; 37(3):484-489.
62. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction [published erratum appears in Am J Kidney Dis. 2001; 38(3):701]. Am J Kidney Dis. 2001; 37(6):1191-1200.
63. Cice TW, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A. Dilated cardiomyopathy in dialysis patients - Beneficial effects of carvedilol: A double-blind, placebo-controlled trial. J Am Coll Cardiol. 2001; 37(2):407-411.